BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2119892)

  • 1. Distinct effects of interferon-gamma and MHC class I surface antigen levels on resistance of the K562 tumor cell line to natural killer-mediated lysis.
    Maziarz RT; Mentzer SJ; Burakoff SJ; Faller DV
    Cell Immunol; 1990 Oct; 130(2):329-38. PubMed ID: 2119892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
    Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
    J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
    Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
    Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
    Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
    J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I expression on human tumour cells and their susceptibility to NK lysis.
    Pena J; Solana R; Alonso MC; Santamaria M; Serrano R; Ramirez R; Carracedo J
    J Immunogenet; 1989; 16(4-5):407-12. PubMed ID: 2517951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the susceptibility to NK-mediated lysis and the simultaneous expression of various surface molecules in anthracyclin-treated K562 cells and in four K562 cell clones.
    Benoist H; Joly P; Broglio C; Jeannesson P; Idoine O; Dufer J; Desplaces A
    Immunol Lett; 1992 Sep; 34(1):45-55. PubMed ID: 1362185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition.
    Riteau B; Menier C; Khalil-Daher I; Martinozzi S; Pla M; Dausset J; Carosella ED; Rouas-Freiss N
    Int Immunol; 2001 Feb; 13(2):193-201. PubMed ID: 11157852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
    Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of natural killer cells with MHC class II: reversal of HLA-DR1-mediated protection of K562 transfectant from natural killer cell-mediated cytolysis by brefeldin-A.
    Jiang YZ; Couriel D; Mavroudis DA; Lewalle P; Malkovska V; Hensel NF; Dermime S; Molldrem J; Barrett AJ
    Immunology; 1996 Mar; 87(3):481-6. PubMed ID: 8778037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of phorbol ester and interferon-alpha: target cell class I HLA antigen expression and resistance to natural killer and lymphokine-activated killer cell-mediated cytolysis.
    Migita K; Eguchi K; Akiguchi I; Ida H; Kawakami A; Ueki Y; Kurata A; Fukuda T; Nagataki S
    Cell Immunol; 1991 May; 134(2):325-35. PubMed ID: 2021973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.
    Stam NJ; Kast WM; Voordouw AC; Pastoors LB; van der Hoeven FA; Melief CJ; Ploegh HL
    J Immunol; 1989 Jun; 142(11):4113-7. PubMed ID: 2541206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of exogenous and endogenous class I MHC genes in a human tumor cell line, K562.
    Maziarz RT; Burakoff SJ; Faller DV
    Mol Immunol; 1990 Feb; 27(2):135-42. PubMed ID: 2108324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2).
    Ciccone E; Pende D; Viale O; Than A; Di Donato C; Orengo AM; Biassoni R; Verdiani S; Amoroso A; Moretta A
    J Exp Med; 1992 Oct; 176(4):963-71. PubMed ID: 1328466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms involved in NK resistance induced by interferon-gamma.
    Ramirez R; Solana R; Carracedo J; Alonso MC; Peña J
    Cell Immunol; 1992 Mar; 140(1):248-56. PubMed ID: 1739986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity.
    Cerboni C; Mousavi-Jazi M; Wakiguchi H; Carbone E; Kärre K; Söderström K
    Eur J Immunol; 2001 Oct; 31(10):2926-35. PubMed ID: 11592068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors.
    Peña J; Alonso C; Solana R; Serrano R; Carracedo J; Ramirez R
    Eur J Immunol; 1990 Nov; 20(11):2445-8. PubMed ID: 1701392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
    Menier C; Riteau B; Carosella ED; Rouas-Freiss N
    Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo.
    Tajima A; Tanaka T; Ebata T; Takeda K; Kawasaki A; Kelly JM; Darcy PK; Vance RE; Raulet DH; Kinoshita K; Okumura K; Smyth MJ; Yagita H
    J Immunol; 2003 Aug; 171(4):1715-21. PubMed ID: 12902470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of HLA class I molecules expression on tumor cell resistance to NK lysis and the IFN-gamma regulatory effect].
    Zhang C; Tian Z; Hou G
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):369-72. PubMed ID: 11810763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.